About 500 Mg Dacarbazin Injection USP
Introducing the top choice for oncology professionals: 500 Mg Dacarbazin Injection USP, a new release known for its impeccable quality and clinically proven efficacy. This elite, prescription-only formulation is offered in a secure, sterile, single-use vial (500 mg/vial), making it a valuable bargain for hospitals and clinics treating various cancers such as malignant melanoma, Hodgkin's lymphoma, and soft tissue sarcoma. With venerable compatibility to both normal saline and 5% dextrose, this lyophilized powder reconstitutes easily, ensuring reliable performance under medical supervision. An odorless vial, protected from light, this product guarantees safety, stability, and extended shelf life. Distributed, exported, and supplied across India.
Trusted by Oncology Experts - Standout Features and Competitive Edge
Used by leading oncology professionals in hospitals, the 500 Mg Dacarbazin Injection USP stands out for its sterile, single-dose vial presentation and impeccable formulation. Its compatibility with both normal saline and 5% dextrose sets it apart from generic alternatives. The product supports streamlined reconstitution and administration under rigorous clinical standards. Primary competitive advantages include long shelf life, odorless quality, and a respected track record-making it the preferred choice in elite cancer care settings.
Payment Terms, Secure Packaging & Efficient Transport Services
Our transaction process is straightforward: charges are transparent with flexible payment terms. Each vial is securely packaged in tamper-evident boxes, ensuring safe transit and storage. Freight and transport services are available from our FOB port in India, allowing for prompt and reliable delivery. We prioritize efficient logistics to guarantee product integrity during transport, making our Dacarbazin Injection a leading choice for distributors, exporters, and traders seeking dependable supply.
FAQ's of 500 Mg Dacarbazin Injection USP:
Q: How should the 500 Mg Dacarbazin Injection USP be administered?
A: The injection must be given intravenously after proper reconstitution, and it should always be administered under qualified medical supervision in a clinical or hospital setting.
Q: What cancers is Dacarbazin Injection primarily used to treat?
A: Dacarbazin Injection is indicated for the treatment of malignant melanoma, Hodgkin's lymphoma, soft tissue sarcoma, and certain other cancers as determined by your oncologist.
Q: When is reconstitution of the vial required?
A: Reconstitution is required immediately before administration. Follow medical guidelines to dissolve the lyophilized powder with normal saline or 5% dextrose just prior to IV use.
Q: Where should the Dacarbazin Injection be stored?
A: The vials should be stored below 25C and protected from light to maintain stability and ensure potency throughout their 24-month shelf life.
Q: What are the primary benefits of using this elite Dacarbazin Injection?
A: Key benefits include high purity, compatibility with commonly used infusion solutions, single-dose convenience, extended shelf life, and proven clinical performance in oncology care.
Q: How does the product ensure safety during transport and handling?
A: The product is packaged in a sterile, single-use vial within tamper-evident boxes, and handled with care using reliable freight and transport services to maintain integrity until delivery.